Yasmin Shakur

Summary

Affiliation: Otsuka Maryland Research Institute
Country: USA

Publications

  1. ncbi request reprint Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart
    Yasmin Shakur
    Otsuka Maryland Research Institute, 9900 Medical Center Drive, Rockville, MD 20850, USA
    Cardiovasc Drugs Ther 16:417-27. 2002
  2. pmc Cyclic nucleotide specific phosphodiesterases of Leishmania major
    Andrea Johner
    Institute for Cell Biology, University of Bern, Baltzerstrasse 4, CH 3012 Bern, Switzerland
    BMC Microbiol 6:25. 2006
  3. ncbi request reprint Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice
    Bing Sun
    Otsuka Maryland Medicinal Laboratories, Inc, 9900 Medical Center Drive, Rockville, MD 20850, United States
    Cell Signal 19:1765-71. 2007
  4. doi request reprint Phosphodiesterases as targets for intermittent claudication
    Yongge Liu
    Otsuka Maryland Medicinal Laboratories, Rockville, MD, USA
    Handb Exp Pharmacol . 2011
  5. ncbi request reprint Cilostazol as a unique antithrombotic agent
    Junichi Kambayashi
    Otsuka Maryland Research Institute, Inc Rockville, MD 20850, USA
    Curr Pharm Des 9:2289-302. 2003
  6. doi request reprint Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases
    Yasmin Shakur
    Otsuka Maryland Medicinal Laboratories Inc, 9900 Medical Center Drive, Rockville, MD 20850, USA
    Handb Exp Pharmacol . 2011

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart
    Yasmin Shakur
    Otsuka Maryland Research Institute, 9900 Medical Center Drive, Rockville, MD 20850, USA
    Cardiovasc Drugs Ther 16:417-27. 2002
    ..However, the lower level of PDE4 activity in failing human heart suggests that factors other than inhibition of PDE4 by milrinone may contribute to differences in cardiotonic action when compared to cilostazol...
  2. pmc Cyclic nucleotide specific phosphodiesterases of Leishmania major
    Andrea Johner
    Institute for Cell Biology, University of Bern, Baltzerstrasse 4, CH 3012 Bern, Switzerland
    BMC Microbiol 6:25. 2006
    ....
  3. ncbi request reprint Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice
    Bing Sun
    Otsuka Maryland Medicinal Laboratories, Inc, 9900 Medical Center Drive, Rockville, MD 20850, United States
    Cell Signal 19:1765-71. 2007
    ..The data suggest that PDE3A is the main subtype of PDE3 expressed in platelets and cardiac ventricular myocytes, and is responsible for the functional changes caused by PDE3 inhibition...
  4. doi request reprint Phosphodiesterases as targets for intermittent claudication
    Yongge Liu
    Otsuka Maryland Medicinal Laboratories, Rockville, MD, USA
    Handb Exp Pharmacol . 2011
    ..Using cilostazol as an example, we discuss the rationales and pitfalls of targeting PDEs in IC, and potential strategies for the development of new and more effective pharmacological treatments...
  5. ncbi request reprint Cilostazol as a unique antithrombotic agent
    Junichi Kambayashi
    Otsuka Maryland Research Institute, Inc Rockville, MD 20850, USA
    Curr Pharm Des 9:2289-302. 2003
    ....
  6. doi request reprint Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases
    Yasmin Shakur
    Otsuka Maryland Medicinal Laboratories Inc, 9900 Medical Center Drive, Rockville, MD 20850, USA
    Handb Exp Pharmacol . 2011
    ....